Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 126

1.

Separate or United: The Safety Net in the Era of Health Care Integration.

Gabow PA, Smith M.

J Health Care Poor Underserved. 2017;28(3):853-859. doi: 10.1353/hpu.2017.0082.

PMID:
28804063
2.

Closing the Health Care Gap in Communities: A Safety Net System Approach.

Gabow PA.

Acad Med. 2016 Oct;91(10):1337-1340.

PMID:
27556674
3.

For many patients who use large amounts of health care services, the need is intense yet temporary.

Johnson TL, Rinehart DJ, Durfee J, Brewer D, Batal H, Blum J, Oronce CI, Melinkovich P, Gabow P.

Health Aff (Millwood). 2015 Aug;34(8):1312-9. doi: 10.1377/hlthaff.2014.1186.

PMID:
26240244
4.

Standards Of Care: The Author Replies.

Gabow P.

Health Aff (Millwood). 2015 Jul;34(7):1254. doi: 10.1377/hlthaff.2015.0657. No abstract available.

PMID:
26153326
5.

The fall: aligning the best care with standards of care at the end of life.

Gabow P.

Health Aff (Millwood). 2015 May;34(5):871-4. doi: 10.1377/hlthaff.2014.1322.

PMID:
25941289
6.

Leaders' engagement key to process of eliminating waste, respecting patients.

Gabow P, Johnson SR.

Mod Healthc. 2014 Feb 10;44(6):28-9. No abstract available.

PMID:
24693650
7.

Geographic disparity. Excluding some of the poorest from health reform shouldn't be an option.

Gabow P.

Mod Healthc. 2013 May 13;43(19):25. No abstract available.

PMID:
23738429
8.

Ten strategies to lower costs, improve quality, and engage patients: the view from leading health system CEOs.

Cosgrove DM, Fisher M, Gabow P, Gottlieb G, Halvorson GC, James BC, Kaplan GS, Perlin JB, Petzel R, Steele GD, Toussaint JS.

Health Aff (Millwood). 2013 Feb;32(2):321-7. doi: 10.1377/hlthaff.2012.1074.

PMID:
23381525
9.

Marshaling leadership for high-value health care: an Institute of Medicine discussion paper.

Gabow P, Halvorson G, Kaplan G.

JAMA. 2012 Jul 18;308(3):239-40. doi: 10.1001/jama.2012.7081. No abstract available.

PMID:
22669121
10.

An 'open door' for the vulnerable. Even after reform is in place, need for safety net providers will be great.

Gabow P.

Mod Healthc. 2011 Aug 8;41(32):24-5. No abstract available.

PMID:
21879696
11.

A broad and structured approach to improving patient safety and quality: lessons from Denver Health.

Gabow PA, Mehler PS.

Health Aff (Millwood). 2011 Apr;30(4):612-8. doi: 10.1377/hlthaff.2011.0042.

PMID:
21471480
12.

Denver Health. Transforming care across the continuum.

Gabow PA.

Hosp Health Netw. 2010 May;84(5):57. No abstract available.

PMID:
20575351
13.

Follow the evidence. Administrative rules, regulations should get comparative-effectiveness treatment.

Gabow P.

Mod Healthc. 2009 Dec 14;39(50):25. No abstract available.

PMID:
20088389
14.

Inspired leadership: Dr. Patricia Gabow talks about pursuing transformation and why mentoring matters.

Gabow PA.

Mod Healthc. 2008 Nov;Suppl:27-9. No abstract available.

PMID:
19133354
15.

Changes in insurance status and access to care in an integrated safety net healthcare system.

Eisert SL, Durfee MJ, Welsh A, Moore SL, Mehler PS, Gabow PA.

J Community Health. 2009 Apr;34(2):122-8. doi: 10.1007/s10900-008-9136-2.

PMID:
18941874
16.

Presence of de novo mutations in autosomal dominant polycystic kidney disease patients without family history.

Reed B, McFann K, Kimberling WJ, Pei Y, Gabow PA, Christopher K, Petersen E, Kelleher C, Fain PR, Johnson A, Schrier RW.

Am J Kidney Dis. 2008 Dec;52(6):1042-50. doi: 10.1053/j.ajkd.2008.05.015. Epub 2008 Jul 21.

17.

Can America's urban safety net systems be a solution to unequal treatment?

Eisert SL, Mehler PS, Gabow PA.

J Urban Health. 2008 Sep;85(5):766-78. doi: 10.1007/s11524-008-9296-5. Epub 2008 Jun 14.

18.

Observations of residents' work activities for 24 consecutive hours: implications for workflow redesign.

Gabow PA, Karkhanis A, Knight A, Dixon P, Eisert S, Albert RK.

Acad Med. 2006 Aug;81(8):766-75.

PMID:
16868436
19.

Prevalence of psychiatric disorders and costs of care among adult enrollees in a Medicaid HMO.

Thomas MR, Waxmonsky JA, Gabow PA, Flanders-McGinnis G, Socherman R, Rost K.

Psychiatr Serv. 2005 Nov;56(11):1394-401.

PMID:
16282258
20.

The effect of automated alerts on provider ordering behavior in an outpatient setting.

Steele AW, Eisert S, Witter J, Lyons P, Jones MA, Gabow P, Ortiz E.

PLoS Med. 2005 Sep;2(9):e255. Epub 2005 Sep 6.

21.

Using computerized clinical decision support for latent tuberculosis infection screening.

Steele AW, Eisert S, Davidson A, Sandison T, Lyons P, Garrett N, Gabow P, Ortiz E.

Am J Prev Med. 2005 Apr;28(3):281-4.

PMID:
15766616
22.

Evaluating patient compliance with nurse advice line recommendations and the impact on healthcare costs.

Bogdan GM, Green JL, Swanson D, Gabow P, Dart RC.

Am J Manag Care. 2004 Aug;10(8):534-42.

23.

Repeat imaging for intracranial aneurysms in patients with autosomal dominant polycystic kidney disease with initially negative studies: a prospective ten-year follow-up.

Schrier RW, Belz MM, Johnson AM, Kaehny WD, Hughes RL, Rubinstein D, Gabow PA.

J Am Soc Nephrol. 2004 Apr;15(4):1023-8.

24.

Genotype-renal function correlation in type 2 autosomal dominant polycystic kidney disease.

Magistroni R, He N, Wang K, Andrew R, Johnson A, Gabow P, Dicks E, Parfrey P, Torra R, San-Millan JL, Coto E, Van Dijk M, Breuning M, Peters D, Bogdanova N, Ligabue G, Albertazzi A, Hateboer N, Demetriou K, Pierides A, Deltas C, St George-Hyslop P, Ravine D, Pei Y.

J Am Soc Nephrol. 2003 May;14(5):1164-74.

25.

Recurrence of intracranial aneurysms in autosomal-dominant polycystic kidney disease.

Belz MM, Fick-Brosnahan GM, Hughes RL, Rubinstein D, Chapman AB, Johnson AM, McFann KK, Kaehny WD, Gabow PA.

Kidney Int. 2003 May;63(5):1824-30.

26.

Denver Health: a model for the integration of a public hospital and community health centers.

Gabow P, Eisert S, Wright R.

Ann Intern Med. 2003 Jan 21;138(2):143-9.

PMID:
12529097
28.

Familial clustering of ruptured intracranial aneurysms in autosomal dominant polycystic kidney disease.

Belz MM, Hughes RL, Kaehny WD, Johnson AM, Fick-Brosnahan GM, Earnest MP, Gabow PA.

Am J Kidney Dis. 2001 Oct;38(4):770-6.

PMID:
11576880
29.

Improvements in billing processes and information systems increase cash collections in a public health care system.

Steele A, Eisert S, Gabow P.

Health Care Manag (Frederick). 2001 Sep;20(1):29-36.

PMID:
11556552
30.

Making a public hospital work.

Gabow PA.

Health Aff (Millwood). 2001 Jul-Aug;20(4):182-7. No abstract available.

PMID:
11463075
31.

Diuretics versus angiotensin-converting enzyme inhibitors in autosomal dominant polycystic kidney disease.

Ecder T, Edelstein CL, Fick-Brosnahan GM, Johnson AM, Chapman AB, Gabow PA, Schrier RW.

Am J Nephrol. 2001 Mar-Apr;21(2):98-103.

PMID:
11359016
32.

Progression of autosomal-dominant polycystic kidney disease in children.

Fick-Brosnahan GM, Tran ZV, Johnson AM, Strain JD, Gabow PA.

Kidney Int. 2001 May;59(5):1654-62.

33.

Von Hippel-Lindau disease masquerading as autosomal dominant polycystic kidney disease.

Chatha RK, Johnson AM, Rothberg PG, Townsend RR, Neumann HP, Gabow PA.

Am J Kidney Dis. 2001 Apr;37(4):852-8.

PMID:
11273887
34.

CF gene and cystic fibrosis transmembrane conductance regulator expression in autosomal dominant polycystic kidney disease.

Persu A, Devuyst O, Lannoy N, Materne R, Brosnahan G, Gabow PA, Pirson Y, Verellen-Dumoulin C.

J Am Soc Nephrol. 2000 Dec;11(12):2285-96.

35.

Progress in blood pressure control in autosomal dominant polycystic kidney disease.

Ecder T, Edelstein CL, Fick-Brosnahan GM, Johnson AM, Duley IT, Gabow PA, Schrier RW.

Am J Kidney Dis. 2000 Aug;36(2):266-71.

PMID:
10922304
36.

Anatomic and metabolic risk factors for nephrolithiasis in patients with autosomal dominant polycystic kidney disease.

Grampsas SA, Chandhoke PS, Fan J, Glass MA, Townsend R, Johnson AM, Gabow P.

Am J Kidney Dis. 2000 Jul;36(1):53-7.

PMID:
10873872
37.

Mutation detection of PKD1 identifies a novel mutation common to three families with aneurysms and/or very-early-onset disease.

Watnick T, Phakdeekitcharoen B, Johnson A, Gandolph M, Wang M, Briefel G, Klinger KW, Kimberling W, Gabow P, Germino GG.

Am J Hum Genet. 1999 Dec;65(6):1561-71.

38.

Evaluation of colonic diverticular disease in autosomal dominant polycystic kidney disease without end-stage renal disease.

Sharp CK, Zeligman BE, Johnson AM, Duley I, Gabow PA.

Am J Kidney Dis. 1999 Nov;34(5):863-8.

PMID:
10561142
39.

Renal asymmetry in children with autosomal dominant polycystic kidney disease.

Fick-Brosnahan G, Johnson AM, Strain JD, Gabow PA.

Am J Kidney Dis. 1999 Oct;34(4):639-45.

PMID:
10516343
40.

Frequency of ovarian cysts in patients with autosomal dominant polycystic kidney disease.

Stamm ER, Townsend RR, Johnson AM, Garg K, Manco-Johnson M, Gabow PA.

Am J Kidney Dis. 1999 Jul;34(1):120-4.

PMID:
10401025
41.

From the bedside to the boardroom.

Gabow PA.

Semin Nephrol. 1999 Mar;19(2):109-14.

PMID:
10192242
42.

Cystic fibrosis and the phenotypic expression of autosomal dominant polycystic kidney disease.

O'Sullivan DA, Torres VE, Gabow PA, Thibodeau SN, King BF, Bergstralh EJ.

Am J Kidney Dis. 1998 Dec;32(6):976-83.

PMID:
9856513
43.
44.

Hypertension in autosomal dominant polycystic kidney disease.

Chapman AB, Gabow PA.

Kidney Int Suppl. 1997 Oct;61:S71-3. Review. No abstract available.

PMID:
9328971
46.

Left ventricular hypertrophy in autosomal dominant polycystic kidney disease.

Chapman AB, Johnson AM, Rainguet S, Hossack K, Gabow P, Schrier RW.

J Am Soc Nephrol. 1997 Aug;8(8):1292-7.

47.

Denver Health: initiatives for survival.

Gabow PA.

Health Aff (Millwood). 1997 Jul-Aug;16(4):24-6. No abstract available.

PMID:
9248146
48.

A peer approach to high risk youth.

Hritz SA, Gabow PA.

J Adolesc Health. 1997 Apr;20(4):259-60.

PMID:
9098728
49.

Utility of ultrasonography in the diagnosis of autosomal dominant polycystic kidney disease in children.

Gabow PA, Kimberling WJ, Strain JD, Manco-Johnson ML, Johnson AM.

J Am Soc Nephrol. 1997 Jan;8(1):105-10.

50.

PKD2, a gene for polycystic kidney disease that encodes an integral membrane protein.

Mochizuki T, Wu G, Hayashi T, Xenophontos SL, Veldhuisen B, Saris JJ, Reynolds DM, Cai Y, Gabow PA, Pierides A, Kimberling WJ, Breuning MH, Deltas CC, Peters DJ, Somlo S.

Science. 1996 May 31;272(5266):1339-42.

PMID:
8650545

Supplemental Content

Support Center